These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16173924)

  • 1. In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling.
    Martin J; Denver R; Bailey M; Krum H
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):697-701. PubMed ID: 16173924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
    Shyu KG; Wang BW; Chen WJ; Kuan P; Hung CR
    Eur J Heart Fail; 2010 Mar; 12(3):219-26. PubMed ID: 20156938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
    Moreno M; Ramalho LN; Sancho-Bru P; Ruiz-Ortega M; Ramalho F; Abraldes JG; Colmenero J; Dominguez M; Egido J; Arroyo V; Ginès P; Bataller R
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G147-56. PubMed ID: 19056767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
    An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
    Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
    Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
    Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.
    Agocha A; Lee HW; Eghbali-Webb M
    J Mol Cell Cardiol; 1997 Aug; 29(8):2233-44. PubMed ID: 9281454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of atorvastatin on the proliferation and collagen synthesis of rat cardiac fibroblasts].
    Tian JW; Zhao LY; Wang SW; Zhang HT; Zheng QS; Yang XD; Xu L; Fan YH
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):118-22. PubMed ID: 12812679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of atorvastatin on cardiac function and TGF-β1 signaling pathway after acute myocardial infarction in rats].
    Song Y; Qiu R; Kuang J; Huang Y; Cai A; Dai G; Mai W
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):202-6. PubMed ID: 22381758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.
    Akahori H; Tsujino T; Naito Y; Matsumoto M; Sasaki N; Iwasaku T; Eguchi A; Sawada H; Hirotani S; Masuyama T
    J Hypertens; 2014 Jul; 32(7):1534-41; discussion 1541. PubMed ID: 24759122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1.
    Araújo FA; Rocha MA; Mendes JB; Andrade SP
    Biomed Pharmacother; 2010 Jan; 64(1):29-34. PubMed ID: 19811885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin suppresses aldosterone-induced neonatal rat cardiac fibroblast proliferation by inhibiting ERK1/2 in the genomic pathway.
    Wang Q; Cui W; Zhang HL; Hu HJ; Zhang YN; Liu DM; Liu J
    J Cardiovasc Pharmacol; 2013 Jun; 61(6):520-7. PubMed ID: 23429584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats.
    Klein S; Klösel J; Schierwagen R; Körner C; Granzow M; Huss S; Mazar IG; Weber S; van den Ven PF; Pieper-Fürst U; Fürst DO; Nattermann J; Lammert F; Sauerbruch T; Trebicka J
    Lab Invest; 2012 Oct; 92(10):1440-50. PubMed ID: 22890553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effect of corticosteroids and long-acting beta(2)-agonists on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts.
    Goulet S; Bihl MP; Gambazzi F; Tamm M; Roth M
    J Cell Physiol; 2007 Jan; 210(1):167-76. PubMed ID: 17013807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.
    Rodrigues Díez R; Rodrigues-Díez R; Lavoz C; Rayego-Mateos S; Civantos E; Rodríguez-Vita J; Mezzano S; Ortiz A; Egido J; Ruiz-Ortega M
    PLoS One; 2010 Nov; 5(11):e14145. PubMed ID: 21152444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation.
    Rodríguez-Vita J; Sánchez-Galán E; Santamaría B; Sánchez-López E; Rodrigues-Díez R; Blanco-Colio LM; Egido J; Ortiz A; Ruiz-Ortega M
    PLoS One; 2008; 3(12):e3959. PubMed ID: 19088845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
    Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin affects several angiogenic mediators in human endothelial cells.
    Dulak J; Loboda A; Jazwa A; Zagorska A; Dörler J; Alber H; Dichtl W; Weidinger F; Frick M; Jozkowicz A
    Endothelium; 2005; 12(5-6):233-41. PubMed ID: 16410222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling.
    Chung CC; Hsu RC; Kao YH; Liou JP; Lu YY; Chen YJ
    Int J Cardiol; 2014 Sep; 176(2):386-93. PubMed ID: 25125004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.